ReturnGo team
ReturnGO, an Israeli startup that has developed a machine-learning-based platform that enables efficient management of returns and exchanges for products purchased online, entered a first-of-its-kind collaboration with Amazon Multi-Channel Fulfillment (“MCF”), which will provide MCF merchants with an integrated solution that automates the entire return and exchange process. Meanwhile, Synaptogenix, a clinical-stage biotech company, entered a new partnership with Cannasoul Analytics in support of research and development of pharmaceutical therapeutics. Synaptogenix took a 25% stake in Cannasoul Analytics for up to $4 million to support R&D for cannabinoid- and psilocybin mushroom-based therapeutics for multiple indications.
Founded in 2018, Cannasoul is a Cannabis analytical laboratoryin the field of medicinal Cannabis providing the “necessary and crucial” information to meet the standards for the development of effective, safe and reliable Cannabis-based products, treatments and pharmaceuticals.
Cannasoul is the first company in the world to analyze over 100 cannabinoids and 100 terpenes. In addition to the comprehensive phytocannabinoid and terpene analysis, Cannasoul offers unique and comprehensive endocannabinoid analysis in a wide range of matrixes.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Under terms of the investment agreement, Synaptogenix obtains a preemptive right to fund the further research and commercialization of certain intellectual property, technology, and future products developed by Cannasoul and licensed from The Technion.
“Cannasoul is pleased to welcome Synaptogenix as a key partner in our development of groundbreaking therapeutics derived from natural compounds. We appreciate the strong support and confidence in our laboratory’s high standards and pioneering scientific approach that this investment represents. Together with Synaptogenix, we look forward to advancing our leadership in developing effective cannabis and psilocybin-based treatments that will be easily accessible to patients worldwide,” stated Professor Peretz Lavie, 16th President of the Technion and Cannasoul Board Member.
ReturnGO was founded in July 2020 by Aviad Raz (CEO), Assi Abramovich (CTO), and Eyal Rosenthal (CRO) and currently employs 20 people at the R&D center in Ramat Gan.
ReturnGO has developed a machine-learning-based platform that enables efficient management of returns and exchanges for products purchased on e-commerce sites.
“Our new integration with MCF further removes friction from the online buying experience and is a win-win for both customers and retailers. We believe it will continue to help retailers improve their operations, increase revenue, and become more sustainable, while providing customers with an even better shopping experience,” said Aviad Raz, Co-Founder and Chief Executive Officer of ReturnGO. “Additionally, we are thrilled to welcome the team at Trestle Partners as an investment partner. Trestle possesses extensive experience in helping SaaS companies strategically grow their businesses, and I am confident they’ll provide us with valuable knowledge and expertise as we look to further scale our platform.”
